← Leaderboards
Elaine Kamil
La Biomed Res Inst/ Harbor Ucla Med Ctr
$22,226
Attributed
$22,226
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.3K · FY2005–09$10K$7.5K$5K$2.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$22,226 · 5
By mechanism
M01$22,226 · 5
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Dechu P Puliyanda$50,907
- Christina C. Wang$7,924,844
- Rajnish Mehrotra$10,175,876
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthBaseBiopsyNatural ImmunosuppressionProtocols DocumentationRandomizedResearch PersonnelResourcesSafetySourceSteroidsTacrolimusAcuteChildhoodComparative TrialComputer Retrieval Of Information On Scientific Projects DatabaseDaclizumabFundingGrantHeightInstitutionKidney TransplantationLiving DonorsClinical Trials
Grant awards (5)
CLINICAL TRIAL: A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH$930
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH$7,309
M01 · FY2008 · RR · contact PI
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS$6,479
M01 · FY2007 · RR · contact PI
RANDOMIZED, MULTICENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS$4,987
M01 · FY2006 · RR · contact PI
RANDOMIZED, MULTICENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND STA$2,521
M01 · FY2005 · RR